Management of localized prostate cancer in senior adults: the crucial role of comorbidity-Reference-Cited by-同舟云学术

Management of localized prostate cancer in senior adults: the crucial role of comorbidity

Published:2008-03 Issue: Volume:101 Page:16-22
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Fitzpatrick John M.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2007.07487.x/fullpdf

Reference33 articles.

1. 1Surveillance Epidemiology and End Results (SEER). SEER data for 2000-2004. National Cancer Institute website. Available at: http://www.cancer.gov. Accessed January 2008

2. 20-year outcomes following conservative management of clinically localized prostate cancer;Albertsen;JAMA,2005

3. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era;D’Amico;J Clin Oncol,2003

4. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer;Albertsen;JAMA,1998

5. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age;Sweat;J Urol,2002

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic Castration-Resistant Prostate Cancer: Advances in Treatment and Symptom Management;Current Treatment Options in Oncology;2024-06-24

2. Alterations of Sexual and Erectile Functions after Brachytherapy for Prostate Cancer Based on Patient-Reported Questionnaires;Prostate Cancer;2024-01-25

3. Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges;Cancers;2023-05-23

4. Cardiovascular outcomes among patients with castration‐resistant prostate cancer: A comparative safety study using US administrative claims data;The Prostate;2023-03-06

5. STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions;Biomedicine & Pharmacotherapy;2023-02